9 Meters Biopharma
NMTR
NMTR was delisted on the 25th of July, 2023.
6 hedge funds and large institutions have $22.7K invested in 9 Meters Biopharma in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 28 closing their positions.
82% less funds holding
Funds holding: 34 → 6 (-28)
99% less capital invested
Capital invested by funds: $2.08M → $22.7K (-$2.05M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 28
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$298K |
| 2 |
SIS
Strategic Investment Solutions
Orland Park,
Illinois
|
+$8.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$437K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$417K |
| 3 |
LCM
Laurion Capital Management
New York
|
-$147K |
| 4 |
BlackRock
New York
|
-$113K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$73.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| – | -$237 | -353 | Closed |
|
27
Osaic Holdings
Scottsdale,
Arizona
| – | -$235 | -350 | Closed |
|
|
PA
28
PSI Advisors
Tampa,
Florida
| – | -$202 | -300 | Closed |
|
|
MA
29
MCF Advisors
Covington,
Kentucky
| – | -$185 | -275 | Closed |
|
30
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$101 | -150 | Closed |
|
31
Fidelity Investments
Boston,
Massachusetts
| – | -$36 | -53 | Closed |
|
32
JP Morgan Chase
New York
| – | -$5 | -7 | Closed |
|
|
RCM
33
Raleigh Capital Management
Cary,
North Carolina
| – | -$1 | -2 | Closed |
|
NMTR Hedge Fund Activity: Q3 2023 in Review
6 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in 9 Meters Biopharma (NMTR) for Q3 2023, worth a combined $22.7K — down 99% from $2.08M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of NMTR and 0 opened new positions — a net loss of 28 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, adding an estimated $298K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $437K sold.
- 6 institutional investors held 9 Meters Biopharma (NMTR) as of Q3 2023, down from 34 in Q2 2023.
- Funds reported $22.7K of 9 Meters Biopharma stock for Q3 2023, down 99% quarter-over-quarter.
- 0 funds opened new 9 Meters Biopharma positions in Q3 2023 and 28 closed out, a net change of -28 holders.
- The largest 9 Meters Biopharma buyer in Q3 2023 was Sabby Management, an estimated $298K added.
- The largest 9 Meters Biopharma seller in Q3 2023 was Adage Capital Partners, an estimated $437K sold.
Based on aggregated 13F filings for Q3 2023.